A study of R&D, innovation, and business performance in the Canadian biotechnology industry

Linda A. Hall, Sharmistha Bagchi-Sen

Research output: Contribution to journalArticlepeer-review

173 Scopus citations


This study examines the relationships among R&D intensity, innovation measures, and business performance in the Canadian biotechnology industry, which experienced rapid growth in the number of firms and revenues between 1994 and 1997. A sample of 74 biotechnology companies in Canada is used for the analysis (the response rate of the postal questionnaire survey was 23.8%). In addition, geographic variations in barriers affecting innovation and factors influencing the business performance of biotechnology firms are analyzed. Results of the study show that R&D intensity correlates with patent measures, while innovation measured in terms of new product introductions is associated with business performance. Canadian firms attribute their business performance to internal advantages to a greater extent than external factors. The Canadian regulatory process is the greatest barrier to innovation. This study shows that while R&D and scientific breakthroughs drive innovation in the biotechnology industry, market demand plays a critical role in business performance of firms.

Original languageEnglish (US)
Pages (from-to)231-244
Number of pages14
Issue number4
StatePublished - Apr 2002
Externally publishedYes


  • Biotechnology
  • Canada
  • Innovation

ASJC Scopus subject areas

  • Engineering(all)
  • Management of Technology and Innovation


Dive into the research topics of 'A study of R&D, innovation, and business performance in the Canadian biotechnology industry'. Together they form a unique fingerprint.

Cite this